Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort.

Name: Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort.
Creator: Yanmei Peng
Published: 2024-03-27T14:46:13.076Z
Keywords: Epidemiology

Peng, Yanmei; Kumar, Ashok; Gu, Zhong; Kosuru, Nikhila; Wampfler, Jason; Reck dos Santos, Pedro; Yu, Nathan; D’Cunha, Jonathan; Costello, Collin; Ernani, Vinicius; Yang, Ping

doi:10.17632/ynnstgsbnj.1

Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort.

Published: 27 March 2024| Version 1 | DOI: 10.17632/ynnstgsbnj.1

Contributors:

Yanmei Peng, Ashok Kumar, Zhong Gu, Nikhila Kosuru, Jason Wampfler, Pedro Reck dos Santos, Nathan Yu, Jonathan D’Cunha, Collin Costello, Vinicius Ernani, Ping Yang

Description

The data included the Supplemental methods, figure and tables for the article "Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort" in Journal of the American Academy of Dermatology.

Files

Institutions

Mayo Clinic Scottsdale

Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort.

Description

Files

Institutions

Categories

Licence